Mangoceuticals (MGRX) Non-cash Items (2022 - 2026)

Mangoceuticals has disclosed Non-cash Items across 5 years of filings, most recently posting $1.2 million for Q1 2026.

• Non-cash Items for Q1 2026 came in at $1.2 million, up 692.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 692.76% YoY), and the FY2025 annual result was $2.2 million, up 1276.6% from the prior year.
• Non-cash Items came in at $1.2 million for Q1 2026 at Mangoceuticals, down from $2.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $2.2 million in Q4 2025 to a low of $133333.0 in Q4 2022.
• The 5-year median for Non-cash Items is $345833.0 (2023), against an average of $646602.5.
• Peak annual rise in Non-cash Items reached 1276.6% in 2025, while the deepest fall reached 92.38% in 2025.
• Mangoceuticals' Non-cash Items stood at $133333.0 in 2022, then surged by 32.5% to $176666.0 in 2023, then declined by 11.32% to $156666.0 in 2024, then surged by 1276.6% to $2.2 million in 2025, then plunged by 46.39% to $1.2 million in 2026.
• The last three Non-cash Items figures came in at $1.2 million (Q1 2026), $2.2 million (Q4 2025), and $654444.0 (Q3 2025), per Business Quant data.